Agenus Inc. (AGEN) financial statements (2021 and earlier)

Company profile

Business Address 3 FORBES ROAD
LEXINGTON, MA 02421
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:1006253607617240
Cash and cash equivalents1006253607113726
Short-term investments    53515
Other undisclosed cash, cash equivalents, and short-term investments  00(0)0 
Receivables116111110 
Inventory, net of allowances, customer advances and progress billings  00000
Inventory  00000
Prepaid expense1171911321
Other current assets2111111
Other undisclosed current assets  (0)(0)0(0) 
Total current assets:1148775749118443
Noncurrent Assets
Operating lease, right-of-use asset337
Property, plant and equipment2726252626156
Intangible assets, net (including goodwill)36343537394225
Goodwill25232323222318
Intangible assets, net (excluding goodwill)1111121416197
Other noncurrent assets4111111
Total noncurrent assets:101696265665832
TOTAL ASSETS:21515513613815724275
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities4645383033197
Accounts payable1714148542
Accrued liabilities2931252228146
Deferred revenue1729
Debt220 001
Deferred revenue and credits4340
Contract with customer, liability2
Other liabilities6002561
Other undisclosed current liabilities59462721   
Total current liabilities:130122685641299
Noncurrent Liabilities
Long-term debt and lease obligation, including:532113142131114 
Long-term debt, excluding current maturities191313142131114 
Finance lease, liability0 
Operating lease, liability348
Other undisclosed long-term debt and lease obligation   (0)(0)  
Liabilities, other than long-term debt404171525286
Deferred revenue and credits812153
Deferred revenue2828
Contract with customer, liability1
Other liabilities2433583
Business combination, contingent consideration, liability1093486 
Other undisclosed noncurrent liabilities203202223    
Total noncurrent liabilities:2962642431581551436
Total liabilities:42638731121419617215
Stockholders' equity
Stockholders' equity attributable to parent, including:(204)(225)(172)(76)(39)7123
Common stock2111111
Additional paid in capital1,2581,0601,005952867851716
Accumulated other comprehensive income (loss)3(1)(2)(2)(2)(2)(2)
Accumulated deficit(1,466)(1,285)(1,177)(1,026)(905)(779)(691)
Other undisclosed stockholders' equity attributable to parent  00000
Stockholders' equity attributable to noncontrolling interest(8)(6)(2)    
Total stockholders' equity:(211)(231)(175)(76)(39)7123
Other undisclosed liabilities and equity   00 36
TOTAL LIABILITIES AND EQUITY:21515513613815724275

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues88150374323257
Cost of revenue(2)      
Gross profit:86150374323257
Operating expenses(202)(214)(162)(150)(128)(99)(45)
Other undisclosed operating income (loss)(1)(6)13(2)(7)(5)
Operating loss:(117)(70)(124)(104)(107)(81)(43)
Nonoperating income (expense)(2)0(2)2(2)(6)2
Investment income, nonoperating  11120
Foreign currency transaction gain (loss), before tax(3)0(2)2(2)(1)1
Interest and debt expense  (11)(31)(19)(0)(1)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes   122(6) 
Loss from continuing operations before income taxes:(119)(70)(137)(121)(127)(93)(42)
Income tax benefit     5 
Loss before gain (loss) on sale of properties:(119)(70)(137)(121)(127)(88)(42)
Other undisclosed net loss(64)(41)(25)    
Net loss:(183)(112)(162)(121)(127)(88)(42)
Net income attributable to noncontrolling interest242    
Net loss attributable to parent:(181)(108)(160)(121)(127)(88)(42)
Preferred stock dividends and other adjustments(0)(0)(0)(0)(0)  
Other undisclosed net loss available to common stockholders, basic     (0)(0)
Net loss available to common stockholders, diluted:(181)(108)(160)(121)(127)(88)(43)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(183)(112)(162)(121)(127)(88)(42)
Other comprehensive income (loss)401(1)1(0)(2)
Comprehensive loss:(179)(111)(161)(121)(126)(88)(44)
Comprehensive income, net of tax, attributable to noncontrolling interest242    
Other undisclosed comprehensive loss, net of tax, attributable to parent     (0)(0)
Comprehensive loss, net of tax, attributable to parent:(177)(107)(159)(121)(126)(88)(45)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: